Abbott Laboratories
ABT
$133.58
-$0.36-0.27%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -5.61% | 3.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.61% | 3.19% | |||
| Cost of Revenue | -10.36% | 5.79% | |||
| Gross Profit | -1.68% | 1.13% | |||
| SG&A Expenses | 5.90% | -0.58% | |||
| Depreciation & Amortization | -9.68% | -1.06% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.04% | 3.39% | |||
| Operating Income | -8.14% | 2.31% | |||
| Income Before Tax | -12.41% | 4.64% | |||
| Income Tax Expenses | 106.29% | -2,548.64% | |||
| Earnings from Continuing Operations | -85.64% | 460.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -85.64% | 460.69% | |||
| EBIT | -8.14% | 2.31% | |||
| EBITDA | -7.62% | 1.86% | |||
| EPS Basic | -85.53% | 458.58% | |||
| Normalized Basic EPS | -3.90% | -2.80% | |||
| EPS Diluted | -85.56% | 460.01% | |||
| Normalized Diluted EPS | -4.34% | -2.33% | |||
| Average Basic Shares Outstanding | -0.39% | 0.38% | |||
| Average Diluted Shares Outstanding | 0.07% | -0.09% | |||
| Dividend Per Share | 0.00% | 7.27% | |||
| Payout Ratio | 6.46% | -0.82% | |||